Clinical Trials Directory

Trials / Completed

CompletedNCT01480752

Reduction of Post-operative Endodontic Pain

the Effect of Intraligamentary Injection of Lornoxicam on the Intensity of Post-operative Endodontic Pain in the Tooth With Symptomatic Irreversible Pulpitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Islamic Azad University, Sanandaj · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Accepted

Summary

To determine the effect of intraligamentary injection of Lornoxicam on the intensity of post-operative endodontic pain in the tooth with symptomatic irreversible pulpitis.

Detailed description

sixty qualified samples (initial estimate which will be come more accurate after the pilot study on 6 patients) will be divided randomly in three groups which all of them will have an inferior Alveolar injection and before the beginning of the treatment the primary group will receive an injection of 0.4 mL ( 0.2 mL in mesio buccal and 0.2 mL in disto buccal) of Lornoxicam and the second group will be injected with 0.4 mL of normal saline( 0.2 mL in mesio buccal and 0.2 mL in disto buccal) ,in third group we will only pretend the injection but actually there is no substance injected ,making the patient believe that there was an injection . Then the patients' pain will be evaluated with visual Analogue Scale analysis (VAS) 0-170 mm in time intervals of 6, 12, 24 and 48 hours after the treatment.

Conditions

Interventions

TypeNameDescription
DRUGLornoxicamPDL injection of 0/2 ml of lornoxicam (4mg/ml),before the root therapy and after the inferior alveolar injection
DRUGnormal salinePDl injection of 0/2 ml normal saline before the root therapy and after inferior alveolar injection
DRUGno injectioninject nothing after inferior alveolar injection and before root canal therapy

Timeline

Start date
2011-09-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2011-11-29
Last updated
2013-01-14

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01480752. Inclusion in this directory is not an endorsement.